<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Specific IgE and IgG measured by the MeDALL allergen-chip depend on allergen and route of exposure: The EGEA study</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-06-22">June 22, 2016.</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>PhD</roleName><forename type="first">Val</forename><surname>Erie Siroux</surname></persName>
							<email>valerie.siroux@univ-grenoble-alpes.fr.</email>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Team of Environmental Epidemiology applied to Reproduction and Respiratory Health</orgName>
								<orgName type="department" key="dep2">Division of Immunopathology</orgName>
								<orgName type="laboratory">Team of Environmental Epidemiology applied to Reproduction and Respiratory Health</orgName>
								<orgName type="institution" key="instit1">INSERM</orgName>
								<orgName type="institution" key="instit2">IAB</orgName>
								<orgName type="institution" key="instit3">Gre-noble; c CHU de Grenoble</orgName>
								<orgName type="institution" key="instit4">IAB</orgName>
								<address>
									<settlement>Grenoble</settlement>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Department of Pathophysiology and Allergy Research</orgName>
								<orgName type="department" key="dep2">Center for Pathophysiology, Infectiology and Immunology</orgName>
								<orgName type="department" key="dep3">Allergology Department</orgName>
								<orgName type="institution" key="instit1">Medical University of Vienna</orgName>
								<orgName type="institution" key="instit2">Vienna; e Assistance Publique-Hôpitaux de Paris</orgName>
								<orgName type="institution" key="instit3">Hôpital Armand-Trousseau</orgName>
								<address>
									<settlement>Paris</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Christian</forename><surname>Lupinek</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Yvonne</forename><surname>Resch</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Mirela</forename><surname>Curin</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Jocelyne</forename><surname>Just</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Institute for Social Medi-cine, Epidemiology and Health Economics</orgName>
								<orgName type="department" key="dep2">Institute for Clinical Epidemiology and Biometry</orgName>
								<orgName type="institution">Universit e Paris</orgName>
								<address>
									<addrLine>6 Pierre et Marie Curie, Ber-lin</addrLine>
									<settlement>Paris, Charit e -Universit€ atsmedizin Berlin</settlement>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Department of Paediatrics</orgName>
								<orgName type="institution">University of W€ urzburg</orgName>
								<address>
									<addrLine>W€ urzburg</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department" key="dep1">Faculty of Medicine</orgName>
								<orgName type="department" key="dep2">Institute of Clinical Medicine</orgName>
								<orgName type="institution">Oslo University Hospital</orgName>
								<address>
									<settlement>Oslo</settlement>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="institution">University of Oslo</orgName>
								<address>
									<settlement>Oslo</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, MSc</roleName><forename type="first">Thomas</forename><surname>Keil</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Renata</forename><surname>Kiss</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Karin</forename><forename type="middle">Lødrup</forename><surname>Carlsen</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Erik</forename><surname>Mel En</surname></persName>
							<affiliation key="aff8">
								<orgName type="institution" key="instit1">the Institute of Environmental Medicine and the Centre for Allergy Research</orgName>
								<orgName type="institution" key="instit2">Karolinska Institutet</orgName>
								<address>
									<settlement>Stockholm</settlement>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="institution">Sachs Children and Youth Hospital</orgName>
								<address>
									<settlement>Stockholm</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Rachel</forename><surname>Nadif</surname></persName>
							<affiliation key="aff10">
								<orgName type="laboratory">INSERM U1168, VIMA (Aging and chronic diseases. Epidemiological and public health approaches)</orgName>
								<address>
									<settlement>Villejuif</settlement>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<orgName type="institution">Univ Versailles St-Quentin-en-Yvelines</orgName>
								<address>
									<settlement>Montigny le Bretonneux</settlement>
								</address>
							</affiliation>
							<affiliation key="aff12">
								<orgName type="department">Department of Otorhinolaryngology</orgName>
								<orgName type="institution">Akershus University Hospital</orgName>
								<address>
									<settlement>Lørenskog</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Isabelle</forename><surname>Pin</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Team of Environmental Epidemiology applied to Reproduction and Respiratory Health</orgName>
								<orgName type="department" key="dep2">Division of Immunopathology</orgName>
								<orgName type="laboratory">Team of Environmental Epidemiology applied to Reproduction and Respiratory Health</orgName>
								<orgName type="institution" key="instit1">INSERM</orgName>
								<orgName type="institution" key="instit2">IAB</orgName>
								<orgName type="institution" key="instit3">Gre-noble; c CHU de Grenoble</orgName>
								<orgName type="institution" key="instit4">IAB</orgName>
								<address>
									<settlement>Grenoble</settlement>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Department of Pathophysiology and Allergy Research</orgName>
								<orgName type="department" key="dep2">Center for Pathophysiology, Infectiology and Immunology</orgName>
								<orgName type="department" key="dep3">Allergology Department</orgName>
								<orgName type="institution" key="instit1">Medical University of Vienna</orgName>
								<orgName type="institution" key="instit2">Vienna; e Assistance Publique-Hôpitaux de Paris</orgName>
								<orgName type="institution" key="instit3">Hôpital Armand-Trousseau</orgName>
								<address>
									<settlement>Paris</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Ingebjørg</forename><surname>Skrindo</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Susanne</forename><surname>Vrtala</surname></persName>
							<affiliation key="aff13">
								<orgName type="department" key="dep1">Department of Pathophysiology and Allergy Research</orgName>
								<orgName type="department" key="dep2">Center for Pathophysiology, Infectiology and Immunology</orgName>
								<orgName type="laboratory">Christian Doppler Laboratory for the Development of Allergen Chips</orgName>
								<orgName type="institution">Medical University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Magnus</forename><surname>Wickman</surname></persName>
							<affiliation key="aff9">
								<orgName type="institution">Sachs Children and Youth Hospital</orgName>
								<address>
									<settlement>Stockholm</settlement>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<orgName type="laboratory">INSERM U1168, VIMA (Aging and chronic diseases. Epidemiological and public health approaches)</orgName>
								<address>
									<settlement>Villejuif</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Josep</forename><forename type="middle">Maria</forename><surname>Anto</surname></persName>
							<affiliation key="aff14">
								<orgName type="laboratory">the Centre for Research in Environmental Epidemiology (CREAL)</orgName>
								<address>
									<settlement>Barcelona</settlement>
								</address>
							</affiliation>
							<affiliation key="aff15">
								<orgName type="institution">IMIM (Hospital del Mar Med-ical Research Institute)</orgName>
								<address>
									<settlement>Barcelona</settlement>
								</address>
							</affiliation>
							<affiliation key="aff16">
								<orgName type="institution">Universitat Pompeu Fabra (UPF)</orgName>
								<address>
									<settlement>Barcelona</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Rudolf</forename><surname>Valenta</surname></persName>
							<affiliation key="aff17">
								<orgName type="laboratory">CIBER Epidemiolog ıa y Salud P ublica (CIBERESP)</orgName>
								<address>
									<settlement>Barcelona</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Jean</forename><surname>Bousquet</surname></persName>
							<affiliation key="aff10">
								<orgName type="laboratory">INSERM U1168, VIMA (Aging and chronic diseases. Epidemiological and public health approaches)</orgName>
								<address>
									<settlement>Villejuif</settlement>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<orgName type="institution">Univ Versailles St-Quentin-en-Yvelines</orgName>
								<address>
									<settlement>Montigny le Bretonneux</settlement>
								</address>
							</affiliation>
							<affiliation key="aff12">
								<orgName type="department">Department of Otorhinolaryngology</orgName>
								<orgName type="institution">Akershus University Hospital</orgName>
								<address>
									<settlement>Lørenskog</settlement>
								</address>
							</affiliation>
							<affiliation key="aff18">
								<orgName type="institution">University Hospital</orgName>
								<address>
									<region>Montpellier</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">Oslo and Lørenskog</orgName>
								<orgName type="institution">University of Grenoble Alpes</orgName>
								<address>
									<addrLine>and Montpellier, W€ urzburg</addrLine>
									<settlement>Grenoble, Paris, Villejuif, Montigny le Bretonneux, Vienna, Stockholm, Barcelona</settlement>
									<country>France, Austria; Berlin, Germany;, Norway, Sweden, Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department">Team of Environmental Epidemiology applied to Reproduction and Respiratory Health</orgName>
								<orgName type="institution">IAB</orgName>
								<address>
									<settlement>Grenoble</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff19">
								<orgName type="department" key="dep1">Institute for Advanced Biosciences</orgName>
								<orgName type="department" key="dep2">All ee des Alpes</orgName>
								<orgName type="laboratory">Centre de recherche UGA-Inserm U1209-CNRS UMR 5309</orgName>
								<orgName type="institution">Val erie Siroux</orgName>
								<address>
									<addrLine>PhD, Site Sant e</addrLine>
									<postCode>38700</postCode>
									<settlement>La Tronche</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Specific IgE and IgG measured by the MeDALL allergen-chip depend on allergen and route of exposure: The EGEA study</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-06-22">June 22, 2016.</date>
						</imprint>
					</monogr>
					<idno type="MD5">B2E249FE397C6FEB9D7C99218BC0C9F2</idno>
					<idno type="DOI">10.1016/j.jaci.2016.05.023</idno>
					<note type="submission">Received for publication November 20, 2015; revised March 21, 2016; accepted for publication May 2, 2016.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:44+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>AstraZeneca, Chiesi, GSK, Meda, Menarini, Merck, MSD, Novartis, Sanofi-Aventis, Takeda, Teva, and Uriach</term>
					<term>receives fees for participation in scientific and advisory boards from Almirall, AstraZeneca, Chiesi, GSK, Meda, Menarini, Merck, MSD, Novartis, Sanofi-Aventis, Takeda, Teva, and Uriach</term>
					<term>and has provision of writing assistance from Almirall, AstraZeneca, Chiesi, GSK, Meda, Menarini, Merck, MSD, Novartis, Sanofi-Aventis, Takeda, Teva, and Uriach</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>The study was supported in part by Inserm Aviesan Itmo sant e publique, the Scientific committee ''AGIR for chronic diseases,'' grant F4605 of the Austrian Science Fund (FWF [Fonds zur F€ orderung der wissenschaftlichen Forschung]) to R.V. and by the European Commission's Seventh Framework 29 Program MeDALL under grant agreement no.</s><s>261357.</s><s>Disclosure of potential conflict of interest: V. Siroux receives grant support from Inserm Aviesan Itmo and receives payment for lectures from Teva, Edimark Sante, Novartis, and AstraZeneca.</s><s>C. Lupinek receives honoria for lectures from Thermo Fisher.</s><s>J. Just serves on the board for ALK Abello, Thermo Fisher, and Astra Zeneca and receives grant support from Novartis and payment for lectures from Stallergenes, ALK, and Novartis.</s><s>K. L. Carlsen receives research support and travel support from Mechanisms of the Development of Allergy European Union funding.</s><s>R. Nadif provides expert testimony for ANSES (The French Agency for Food, Environmental and Occupational Health &amp; Safety) and receives grant support from PHRC (programme hospitalier de recherche clinique) 2012.</s><s>I. Pin receives payment for lectures from Novartis and receives travel support from Novartis and Aptalis.</s><s>S. Vrtala receives grant support from the Austrian Science Fund and Christian Doppler Research Association.</s><s>M. Wickman receives research support from ThermoFisher Scientific; serves as a consultant for Meda; and receives payment for lectures from Stallergens.</s><s>R. Valenta receives grant support from the European Union, Austrian Science Fund FWF, Biomay AG, ThermoFisher, and Fresensius Medical Care and serves as a consultant for Biomay A, ThermoFisher, and Fresenius Medical Care.</s><s>J. Bousquet receives payment for lectures from Almirall,</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: The nature of allergens and route and dose of exposure may affect the natural development of IgE and IgG responses.</s><s>Objective: We sought to investigate the natural IgE and IgG responses toward a large panel of respiratory and food allergens in subjects exposed to different respiratory allergen loads.</s><s>Methods: A cross-sectional analysis was conducted in 340 adults of the EGEA (Epidemiological study of the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy) (170 with and 170 without asthma) cohort.</s><s>IgE and IgG responses to 47 inhalant and food allergen components were analyzed in sera using allergen microarray and compared between 5 French regions according to the route of allergen exposure (inhaled vs food allergens).</s><s>Results: Overall 48.8% of the population had allergen-specific IgE levels of 0.3 ISAC standardized units (ISU) or more to at least 1 of the 47 allergens with no significant differences across the regions.</s><s>For ubiquitous respiratory allergens (ie, grass, olive/ash pollen, house dust mites), specific IgE did not show marked differences between regions and specific IgG (&gt; _0.5 ISU) was present in most subjects everywhere.</s><s>For regionally occurring pollen allergens (ragweed, birch, cypress), IgE sensitization was significantly associated with regional pollen exposure.</s><s>For airborne allergens cross-reacting with food allergens, frequent IgG recognition was observed even in regions with low allergen prevalence (Bet v 1) or for allergens less frequently recognized by IgE (profilins).</s><s>Conclusions: The variability in allergen-specific IgE and IgG frequencies depends on exposure, route of exposure, and overall immunogenicity of the allergen.</s><s>Allergen contact by the oral route might preferentially induce IgG responses.</s><s>(J Allergy Clin Immunol 2017;139:643-54.)</s><s>Key words: IgE, IgG, allergen components, respiratory allergens, food allergens, EGEA, cohort, epidemiology, MeDALL, microarray Allergic patients are characterized by the production of specific IgE antibodies against allergens, 1 whereas allergen-specific IgG antibodies occur in both allergic and nonallergic individuals. <ref type="bibr" target="#b1">2</ref></s><s>4]<ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref> For certain allergens, IgE and IgG responses differ. <ref type="bibr" target="#b7">8</ref></s><s>Allergen-specific IgG antibodies may be associated with exposure to the respective allergen. <ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b9">10</ref></s><s>owever, population data regarding the role of the production of IgG antibodies to a broad panel of common food and inhalant allergens are not available.</s></p><p><s>The route and dose of exposure to allergens are highly relevant for IgE and IgG sensitization.</s><s>The oral route may favor an IgG response, whereas inhaled exposure may favor an IgE response. <ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b10">11</ref></s><s>Investigating the IgG response to several molecule groups such as profilins (eg, Bet v 2 and Phl p 12), including both inhalant and food allergens, or polcalcins, that is, calciumbinding allergens (eg, Bet v 4 and Phl p 7), including only inhalant allergens, could provide additional insight into the role of the route of exposure for allergic sensitization.</s></p><p><s>The microarray technology allows measurement of allergenspecific IgE and IgG antibody responses to many allergen components.</s><s>3]<ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref> The resulting MeDALL chip has been validated <ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b15">16</ref> and more than 6000 sera from 7 European birth cohorts (eg, Barn, Allergi, Milj€ o, Stockholm, Epidemiologi [BAMSE] and Environment and Childhood Asthma [ECA]) <ref type="bibr" target="#b16">17,</ref><ref type="bibr" target="#b17">18</ref> have been tested so far.</s></p><p><s>The Epidemiological study of the Genetics and Environment of Asthma, bronchial hyperresponsivness and atopy (EGEA) <ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref> is a cohort of adults and children with and without asthma recruited in 5 French cities (Paris, Lyon, Grenoble, Montpellier, and Marseille).</s><s>Pollen exposure varies widely among these different places.</s><s>Grass pollen exposure is similar across France, whereas exposure to pollens of birch, cypress, and ragweed exhibits strong geographical variability.</s></p><p><s>As part of the MeDALL project, <ref type="bibr" target="#b14">15</ref> the present study investigates the geographical variability of allergen-specific IgE and IgG antibodies toward a large variety of different respiratory and food allergens using the MeDALL microarray technology in sera from the EGEA cohort obtained from subjects recruited in different places in France.</s><s>We addressed whether there are differences among the types of allergens, routes of allergen exposure, and levels of respiratory allergen exposure on the production of allergen-specific IgE and IgG antibodies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Population and study setting</head><p><s>The EGEA cohort is composed of patients with asthma enrolled in chest clinics and their first-degree relatives, and a group of control subjects, all recruited in the early 1990s in 5 French cities.</s><s>Protocol and characteristics have been previously published. <ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b22">23</ref></s><s>Briefly, 2047 participants were enrolled at baseline (EGEA1) including 388 children (&lt;16 years) and adult patients with asthma from chest clinics, their 1244 first-degree relatives, and 415 population-based control subjects.</s><s>Subjects were recruited through self-completed questionnaires and an overall matching by months at examination, age (decade), sex, and center.</s><s>About 11 years later, this population was invited for a follow-up (EGEA2) and 1601 participants (77.1% of the original cohort 1 58 new family members) were subjected to a complete examination, which included serum samples. <ref type="bibr" target="#b20">21</ref></s><s>EGEA collection is certified ISO 9001 and referenced in the Biobank network by the number BB-0033-00043.</s></p><p><s>The present analysis was conducted in 340 adult participants obtained at the follow-up (ie, EGEA2) (170 with and 170 without asthma).</s><s>Participants were randomly selected among all followed-up subjects with available serum and data on genetic polymorphisms (to facilitate further analyses), skin prick tests (SPTs), and total IgE at baseline (EGEA1) and follow-up (EGEA2) visits and nonmissing data for asthma status.</s></p><p><s>Written consent was obtained from all individuals.</s><s>Ethical approval was obtained for both surveys (Cochin Royal Hospital, Paris, for EGEA1 and Necker-Enfants Malades Hospital, Paris, for EGEA2).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Asthma, allergic rhinitis phenotypes, and SPTs</head><p><s>The definition of ever asthma was based on a positive answer to either ''Have you ever had attacks of breathlessness at rest with wheezing?''</s><s>or ''Have you ever had asthma attacks?''</s><s>or being recruited as an asthma case. <ref type="bibr" target="#b22">23</ref></s><s>Allergic rhinitis ever was defined by a positive answer to ''Have you ever had allergic rhinitis?''</s><s>or ''Have you ever had hay fever?''</s><s>Subjects with a positive answer to ''Have you had a problem with sneezing or runny or blocked nose when you did not have a cold or flu in the last 12 months'' have been defined as active allergic rhinitis.</s></p><p><s>SPT was performed for 11 allergens (cat, Dermatophagoides pteronyssinus, Blattela germanica, olive, birch, Parieteria judaica, timothy grass, ragweed pollen, Aspergillus, Cladosporium herbarum, Alternaria tenuis).</s><s>Positive SPT result was defined by a mean wheal diameter of 3 mm or more.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Measurement of allergen-specific IgE and IgG levels with the MeDALL allergen-chip</head><p><s>IgE and IgG levels were determined in anonymized samples with the MeDALL allergen-chip as described. <ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b15">16</ref></s><s>It comprises 176 allergen components including aero-and food allergen components.</s><s>The measurement of allergen-specific IgE and IgG reactivities was performed as described. <ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b17">18,</ref><ref type="bibr" target="#b23">24</ref></s><s>he present study was focused on outdoor allergen sources whose distribution varied in the different geographical areas (birch pollen, cypress pollen, ragweed pollen, olive/ash pollen, timothy grass pollen) and on allergens from indoor allergen sources (house dust mites).</s><s>We studied IgG to the pathogenesis-related protein family PR-10 (PR-10) group of allergens with cross-reactive food allergens. <ref type="bibr" target="#b17">18</ref></s><s>To further address the hypothesis that allergen contact mainly by the oral route induces IgG response, 3 common food allergens were also studied (milk, egg, fish), allowing us to compare the frequency of IgE and IgG recognition across respiratory and food allergens.</s><s>Overall, 47 representative allergen components were analyzed in detail.</s><s>French aerobiology network in charge of the analysis of biological particles in air samples (http://www.pollens.fr). <ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b25">26</ref></s><s>Data are presented as the daily mean of grains/m 3 across the year 2006, a year included in the EGEA2 data collection period (2003-2007).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Geographical exposure to allergens</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Biases</head><p><s>The random selection of the EGEA2 participants to the present analysis was a priori unrelated to allergen exposure and allergic status, minimizing the risk for selection bias.</s><s>In both subjects with and without asthma, subjects included in the analysis did not differ regarding allergic sensitization as defined by 1 or more positive reaction in SPT using 12 different extracts, level of total IgE, and allergic rhinitis phenotype as compared with exluded participants (see Table <ref type="table" target="#tab_5">E1</ref> in this article's Online Repository at www.jacionline.org).</s><s>Regarding exposure we did not observe marked differences between included and excluded subjects, although included subjects with asthma were more often recruited in Lyon and Grenoble (Table <ref type="table" target="#tab_5">E1</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical methods</head><p><s>7]<ref type="bibr" target="#b17">[18]</ref> Ordinal categorical variables were also studied both for IgE (&lt;0.3 &lt;1 &lt;3 &lt;10 &lt;30 and &gt; _30 ISU) and for IgG (&lt;0.5 &lt;1.5 &lt;5 &lt;15 &lt;50 and &gt; _50 ISU) because of the non-Gaussian distribution.</s><s>Chi-square test was used when applicable.</s><s>Nonparametric Kruskal-Wallis tests were also applied to address whether the IgE and IgG levels (considered as continuous outcomes) differed among centers.</s><s>Odds ratios were estimated to assess the magnitude of the association between centers and allergen-specific IgE (or IgG) sensitization using multinomial logistic regression adjusted on age, sex, asthma, and rhinitis status.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Characteristics of study subjects</head><p><s>In this study, 340 sera from different centers (Paris: n 5 96; Lyon: n 5 75; Marseille: n 5 41; Montpellier: n 5 22; Grenoble: n 5 106) were available.</s><s>The demographic characteristics of participants are presented in Table <ref type="table" target="#tab_2">I</ref>.</s><s>The population included 47% men, and the mean age was 43 years.</s><s>Fifty-two percent of participants had allergic rhinitis ever and 37.6% had atopic dermatitis ever.</s><s>Eighty-two participants reported having received some form of allergen immunotherapy (AIT).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Allergens most frequently recognized by IgE</head><p><s>Overall, 48.8% of the population had allergen-specific IgE level of 0.3 ISU or more to at least 1 of the allergen components selected, which is in strong agreement with the prevalence of atopy (defined by positive SPT result to at least 1 of 11 aeroallergen extracts) in this population (Cohen k coefficient 5 0.68).</s><s>The agreement between SPT and allergenspecific IgE was strong for each allergen (see  <ref type="table" target="#tab_3">II</ref>). Regarding food allergens, the family of PR-10 proteins (ie, Mal d 1: apple; Cor a 1.0401: hazelnut; Ara h 8: peanut; Pru p 1: cherry; Gly m 4: soy) that cross-react with the major birch pollen allergen Bet v 1 were most frequently recognized by IgE (from 2.4% to 7.6% of patients), followed by Gal d 1 (ovomucoid, egg) and Bos d 4 (lactalbumin, milk), with 0.6% and 0.3%.</s><s>These patterns were consistent in the population that did not receive AIT, although the prevalence of IgE recognition was lower as compared with the whole study population (Table <ref type="table" target="#tab_3">II</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Similarities and discrepancies between IgE and IgG recognition</head><p><s>Distinct patterns of IgE and IgG recognition frequencies were found (Table <ref type="table" target="#tab_3">II</ref>).</s><s>In general, respiratory allergens (Ole e 1, Phl p 1, Phl p 4, Der p 1, Der p 2, Der p 23, Fel d 1) frequently recognized by IgE antibodies (&gt; _20% subjects) were frequently recognized by IgG as well (&gt; _60% subjects).</s><s>Likewise, some respiratory allergens less frequently recognized by IgE antibodies (&lt; _6% subjects) were also recognized at low frequency (ie, &lt;40%) by IgG (Phl p 7, Phl p 11, Bet v 4, Ole e 7, Amb a 1).</s><s>However, other respiratory allergens also less frequently recognized by IgE antibodies were recognized in more than 80% by IgG (Phl p 12, Bet v 2, Ole e 9).</s><s>Similar patterns were observed in the population without AIT.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Geographical variation of IgE and IgG recognition</head><p><s>Although the IgE sensitization to at least 1 of the analyzed allergens (Table <ref type="table" target="#tab_3">II</ref>) did not vary significantly across the geographical areas (from 39.0% to 54.7%; P 5 .46),</s><s>we observed considerable geographical differences for some specific allergens (Fig <ref type="figure" target="#fig_1">1</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>and Table III).</head><p><s>For several major respiratory allergens, the IgE and IgG frequencies in the different regions followed to a large extent the exposure levels with the corresponding allergen sources (eg,  However, for Bet v 1 the geographic pattern of IgE and IgG recognition differed.</s><s>IgE recognition frequencies to Bet v 1 followed the exposure levels of birch pollen in the different regions, whereas IgG recognition was high (&gt;60%) in all regions.</s><s>This was also observed for food allergens that showed immunological cross-reactivity with Bet v 1 (PR-10 proteins, eg, Mal d 1 from apple, Cor a 1.0401 from hazelnut, Ara h 8 from peanut, Pru p 1 from cherry, and Gly m 4 from soy) (Fig <ref type="figure" target="#fig_3">1)</ref>.</s></p><p><s>Regarding ubiquitously occurring allergens such as highly cross-reactive plant allergens (calcium-binding allergens: Phl Very few subjects showed IgE reactivity to allergens of milk (Bos d 4) and egg (Gal d 1), and these allergens were recognized by IgG in about 90% of the subjects with no differences across the geographical areas (Fig <ref type="figure">3)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>Microarrayed allergens are increasingly used to determine the molecular profile of IgE sensitization in populations. <ref type="bibr" target="#b26">27,</ref><ref type="bibr" target="#b27">28</ref></s><s>owever, to our knowledge, the present study is the first systematic study comparing IgE and IgG responses to a large panel of respiratory and food allergens in a geographically defined population.</s><s>It shows a large geographical variability in the distribution of IgE and IgG antibodies in France, which could be summarized as follows: (1) for ubiquitous allergens such as pollens of grass, olive/ash, and to a lesser extent allergens from house dust mites, IgE antibodies were scattered around the different French regions (up to 34% of participants) and IgG antibodies were present in most subjects without any geographical difference (&gt;85%).</s><s>(2) However, for regional pollen (ragweed, birch, cypress), IgE responses mirrored regional pollen exposure, but the IgG responses varied depending on allergen sources: high for pollen allergens cross-reacting with food allergens (Bet v 1 and other PR-10 allergen components) and glycosylated components (eg, Cup a 1 and Phl p 4), <ref type="bibr" target="#b28">29</ref> low for the other pollen allergens with only respiratory exposure, and no cross-reactivity with food allergens (eg, ragweed).</s><s>(3) For food allergens, IgG responses were frequent whereas IgE responses were rare.</s><s>These results indicate that contact with allergen by the oral route may preferentially induce IgG responses whereas allergen contact by the respiratory route appears important for IgE sensitization.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Strengths and weaknesses</head><p><s>One strength lies in the solid phenotypic characterization of a large population, with a fair distribution of asymptomatic subjects and subjects with asthma and/or rhinitis.</s><s>As in most epidemiological settings, the definitions of asthma and rhinitis were based on a standardized questionnaire, which might have led to misclassification bias on the disease status, but should not have biased our results on the effects of the geographical area and routes of exposure in IgE and IgG recognition.</s><s>As compared with the general population, our study population is enriched with subjects with asthma and consequently has higher percentages of IgE sensitizations, leading to an increased statistical power to address allergen-specific IgE responses.</s><s>Indeed, because the main aim of the present study was the parallel analysis of allergen-specific IgE and IgG responses toward a comprehensive set of allergen molecules to dissect variations in geographic sensitization profiles and possible routes of sensitization, a normal population would not have been appropriate because the percentage of allergic subjects would have been too low and it would have required a much larger sample size.</s><s>This population selection should not have affected our results on the geographical variability of IgE and IgG sensitization, but does not allow assessing the community-based prevalence of IgE and IgG responses.</s><s>The study is specific to France, but can help to understand and assess the differences between ubiquitous and regional allergens in other countries as well as IgE and IgG responses to allergens in general.</s></p><p><s>The effect of immunotherapy on specific IgE or specific IgG levels could not be tested because only allergic patients had received this form of treatment and there will necessarily be higher frequencies of IgE recognition in individuals who received AIT than in those who did not.</s><s>However, the frequency of subjects who had received AIT was similar across centers and even though AIT induces IgG it does not completely eliminate IgE reactivity to the microarrayed allergens and therefore does not affect the geographic IgE results.</s><s>Although we do not have detailed information on AIT (regarding the targeted allergens), we do not think that AIT might differentially influence the IgE/IgG profile according to the allergen.</s><s>For instance, it is unlikely that subjects in areas without birch pollen developed IgG against this allergen (ie, Bet v 1 and Bet v 1-related food allergens) due to AIT because birch pollen-specific AIT was probably not prescribed in this area.</s><s>Also, naturally occurring IgG does not affect IgE recognition in the chip analysis because naturally occurring IgG seems to react with epitopes different from those recognized by IgE. <ref type="bibr" target="#b7">8</ref> Finally, the sensitivity analysis conducted among subjects not having received AIT showed strong robustness of the observed associations.</s></p><p><s>The exposure to allergens was not addressed at the individual level, but by study center locations.</s><s>This ecological approach for exposure assessment might be a source of exposure misclassification, characterized here by the Berkson error type, which has been shown to weaken the precision of the estimates, but as compared with the classical error does not induce major bias on risk estimates. <ref type="bibr" target="#b29">30</ref></s><s>Also, we considered the center of recruitment and did not take into account the residential history of the participants.</s><s>This may have led to exposure misclassification because some individuals might have lived in different areas with potentially different exposures.</s></p><p><s>A major strength relates to the use of the improved microarray technology, which contains a larger number of important allergens than do the commercial ISAC chips. <ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b15">16</ref></s><s>The MeDALL chip used in this study is as sensitive for IgE detection as the quantitative ImmunoCAP assay and can be used also for the detection of allergen-specific IgG responses with high specificity and sensitivity. <ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b15">16</ref></s><s>Furthermore, the allergen repertoire on the MeDALL chip covers most of the relevant allergen sources. <ref type="bibr" target="#b16">17</ref></s><s>lthough IgG can interfere with IgE binding on allergen microarrays, we have proven that it does not affect the sensitivity to pick up sensitizations. <ref type="bibr" target="#b16">17</ref></s><s>Moreover, we found that IgE results were in good agreement with results obtained by skin prick testing.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Interpretation of the results</head><p><s>In accordance with a recent cross-sectional analysis in the United States, IgE sensitization to at least 1 of the studied allergens did not vary across the French regions but allergenspecific sensitization against some allergen components exhibited geographical variations. <ref type="bibr" target="#b30">31</ref></s><s>This may indicate that genetic susceptibility for sensitization, probably similar across the country, favors an IgE immune response in the same percentage of the population overall, but specificities of IgE reactions are linked to exposure.</s><s>3]<ref type="bibr" target="#b33">[34]</ref> Patients with a subclinical sensitization to birch pollen exist in an area without atmospheric birch pollen exposure. <ref type="bibr" target="#b34">35</ref></s><s>For cypress pollen, IgE patterns also reflect pollen dispersion but IgG is found in most participants because of the carbohydrate nature of the allergen, which makes it a panallergen. <ref type="bibr" target="#b28">29</ref></s><s>The lower IgE recognition frequency of Der p 1 and Der p 2 in Lyon was a priori not expected but might be related to factors such as living habits.</s></p><p><s>Some respiratory allergens induce IgG only in few patients because they are poorly immunogenic (eg, Phl p 2) but nevertheless they often lead to IgE sensitization. <ref type="bibr" target="#b35">36,</ref><ref type="bibr" target="#b36">37</ref></s><s>This follows properties of the antigens themselves.</s><s>We found that IgG reactivity to the highly cross-reactive pollen allergens Phl p 12 and Bet v 2 (ie, profilins) <ref type="bibr" target="#b37">38</ref> and PR-10 proteins <ref type="bibr" target="#b38">39</ref> was very common in each region, whereas IgE and IgG reactivity to another class of cross-reactive pollen allergens, the calciumbinding allergens from birch (Bet v 4) and timothy grass (Phl p 7), was low in all regions.</s><s>PR-10 and profilins are present in pollen and plant-derived foods, whereas the polcalcins, that is, calcium-binding allergen components, are present only in pollen.</s><s>This probably explains the differences in IgG reactivity between PR-10 and profilins (high) in comparison to calcium-binding components (low).</s><s>This is supported by a recent study suggesting that foodborne PR-10 allergens initiate an early IgG response to PR-10 molecules but no IgE response. <ref type="bibr" target="#b10">11</ref></s><s>Certain house dust mite allergens that are rare targets for IgE (Der p 10, Der p 11, and Der p 14, &lt;10% in our population) are frequently recognized by IgG antibodies (&gt;60% in our population).</s><s>Interestingly, these allergens are mainly present in mite bodies and therefore allergen contact occurs mainly via the skin <ref type="bibr" target="#b39">40</ref> or via cross-reactive food allergens (eg, Der p 10 is cross-reactive with tropomyosin from shrimp).</s></p><p><s>In conclusion, the results from the analysis of IgE and IgG responses against a comprehensive set of respiratory and food allergens in the present study suggest that IgG response is related to exposure via the respiratory tract, the gastrointestinal tract, and possibly via the skin whereas IgE sensitization occurs mainly when the subject is exposed via the respiratory tract.</s><s>However, only a fraction of these subjects develops IgE antibodies. <ref type="bibr" target="#b17">18</ref></s><s>The results of the present study will be valuable for better understanding when allergen-specific interventions such as avoidance or immunotherapy should be undertaken or not.</s><s>We thank all those who participated in the setting of the study and in the various aspects of the examinations involved: interviewers; technicians for lung function testing, SPTs, and IgE determinations; coders; those involved in quality control and data and sample management; and all those who supervised the study in all centers.</s><s>We are also grateful to the biobanks in Lille (CIC-Inserm) and Annemasse (Etablissement franc ¸ais du sang) where biological samples are stored.</s><s>We are indebted to all the individuals who participated, without whom the study would not have been possible.</s></p><p><s>We thank the R eseau National de Surveillance A erobiologique, the French aerobiology network in charge of the analysis of biological particles in air samples, for providing access to the data of pollen concentrations across France.</s><s>We thank Rob Aalberse, Amsterdam, The Netherlands, for thoughtful discussions.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Key messages</head><p><s>d IgE and IgG antibodies toward respiratory allergens are usually associated with inhalant allergen exposures, but IgG is frequent in subjects exposed to cross-reacting food allergens.</s></p><p><s>d Oral exposure preferentially induces IgG responses.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>p 7 and Bet v 4; profilins: Phl p 12 and Bet v 2), house dust mite allergens (eg, Der p 1, Der p 2, Der p 23, Der p 10, Der p 11, and Der p 14), and food allergens whose sensitization occurs primarily by the oral route (eg, Bos d 4, Gal d 1, and Gad c 1), we found little geographic variation for IgE and IgG recognition frequencies (Figs 1 and 2).</s><s>Nevertheless, for some of these allergen components, IgG concentrations varied across the regions (as indicated by the nonparametric Kruskal-Wallis test estimated on the continuous variables) and IgE reactivity against major indoor allergens from house dust mite (ie, Der p 2, Der p 23, Der p 1) tended to be lower in Lyon and Marseille (Fig 2).</s><s>In each region, Der p 10, Der p 11, and Der p 14, for which exposure also occurs via the gut (Der p 10 cross-reacts with tropomyosin from shrimp) or the skin, were rarely recognized by IgE but frequently by IgG (Table II and Fig 2).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>FIG 1 .</head><label>1</label><figDesc><div><p><s>FIG 1. IgE and IgG recognition frequencies and intensities for genuine pollen marker allergens from ragweed (Amb a 1) (A), birch (Bet v 1) (B), cypress (Cup a 1) (C), olive/ash (Ole e 1) (D), and timothy grass (Phl p 1) (E) and for cross-reactive pollen allergens timothy grass polcalcin (Phl p 7) (F), birch polcalcin (Bet v 4) (G), timothy grass profilin (Phl p 12) (H), and birch profilin (Bet v 2) (I), and for the Bet v 1-related food allergen from apple (Malus domestica 1) (J) in different regions of France.</s><s>Shown are the percentages of subjects (y-axes) with IgE (upper panels) and IgG reactivity (middle panels) to the allergens in the different cities of France (x-axes) and the pollen counts in the different areas of France (lower panels).</s><s>Antibody levels are color-coded and shown in ISU.</s><s>P values assessing the differences across centers were estimated from the nonparametric Kruskal-Wallis test.</s></p></div></figDesc><graphic coords="5,43.31,65.59,502.26,380.41" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>FIG 1 .</head><label>1</label><figDesc><div><p><s>FIG 1. (Continued).</s></p></div></figDesc><graphic coords="6,99.27,65.59,382.76,416.86" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>FIG 1 .</head><label>1</label><figDesc><div><p><s>FIG 1. (Continued).</s></p></div></figDesc><graphic coords="8,64.91,65.59,191.27,298.21" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head></head><label></label><figDesc><div><p><s>We thank the EGEA cooperative group: Coordination: V.Siroux (epidemiology, PI since 2013); F. Demenais (genetics); I. Pin (clinical aspects); R. Nadif (biology); and F. Kauffmann (PI 1992-2012).</s><s>Respiratory epidemiology: Inserm U 700, Paris: M. Korobaeff (EGEA1), F. Neukirch (EGEA1); Inserm U 707, Paris: I. Annesi-Maesano (EGEA1-2); Inserm CESP/U 1018, Villejuif: F. Kauffmann, N. Le Moual, R. Nadif, M.P. Oryszczyn (EGEA1-2), R. Varraso; Inserm U 823, Grenoble: V. Siroux.</s><s>Genetics: Inserm U 393, Paris: J. Feingold; Inserm U 946, Paris: E. Bouzigon, F. Demenais, M.H. Dizier; CNG, Evry: I. Gut (now CNAG, Barcelona, Spain), M. Lathrop (now Univ McGill, Montreal, Canada).</s><s>Clinical centers: Grenoble: I. Pin, C. Pison; Lyon: D. Ecochard (EGEA1), F. Gormand, Y. Pacheco; Marseille: D. Charpin (EGEA1), D. Vervloet (EGEA1-2); Montpellier: J. Bousquet; Paris Cochin: A. Lockhart (EGEA1), R. Matran (now in Lille); Paris Necker: E. Paty (EGEA1-2), P. Scheinmann (EGEA1-2); Paris-Trousseau: A. Grimfeld (EGEA1-2), J. Just.</s><s>Data and quality management: Inserm ex-U155 (EGEA1): J. Hochez; Inserm CESP/U 1018, Villejuif: N. Le Moual; Inserm ex-U780: C. Ravault (EGEA1-2); Inserm ex-U794: N. Chateigner (EGEA1-2); Grenoble: J Quentin-Ferran (EGEA1-2).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>FIG 2 .</head><label>2</label><figDesc><div><p><s>FIG 2. IgE and IgG recognition frequencies and intensities for respiratory house dust mite allergens derived from mite feces, that is, Der p 1 (A), Der p 2 (B), and Der p 23 (C) and from mite bodies, that is, Der p 10 (D), Der p 11 (E), and Der p 14 (F), respectively.</s><s>Shown are the percentages of subjects (y-axes) with IgE (upper panels) and IgG (lower panels) reactivity to the allergens in the different cities of France (x-axes).</s><s>Antibody levels are color-coded and shown in ISU.</s><s>P values assessing the differences across centers were estimated from the nonparametric Kruskal-Wallis test.</s></p></div></figDesc><graphic coords="10,39.52,70.98,502.26,545.73" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>FIG E1 .</head><label>E1</label><figDesc><div><p><s>FIG E1.</s><s>IgE and IgG recognition frequencies and intensities in subjects not reporting AIT for ragweed (Am b a1) (A), birch (Bet v 1) (B), Cypress (cup a 1) (C), timothy grass (Phl p 1) (D), houst dust mite (Der p 1) (E), house dust mite (Der p 10) (F), and apple (Mal d 1) (G).</s><s>Mal d, Malus domestica.</s></p></div></figDesc><graphic coords="13,43.31,66.45,502.26,579.29" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="7,103.07,70.98,382.76,589.10" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="11,43.31,65.59,502.26,158.51" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="14,64.35,65.59,192.46,304.38" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head></head><label></label><figDesc><div><p><s>The geographical distribution of the studied pollens across France in 2006 was obtained from the R eseau National de Surveillance A erobiologique, the</s></p></div></figDesc><table><row><cell>Abbreviations used</cell></row><row><cell>AIT: Allergen immunotherapy</cell></row><row><cell>Bet v: Betula verrucosa</cell></row><row><cell>EGEA: Epidemiological study of the Genetics and Environment of</cell></row><row><cell>Asthma, bronchial hyperresponsiveness and atopy</cell></row><row><cell>ISU: ISAC standardized units</cell></row><row><cell>MeDALL: Mechanisms of the Development of Allergy</cell></row><row><cell>Phl p: Phleum pratense</cell></row><row><cell>PR-10: Pathogenesis-related protein family PR-10</cell></row><row><cell>SPT: Skin prick test</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head></head><label></label><figDesc><div><p><s>Table E2 in this article's Online Repository at www.jacionline.org).</s><s>Pollen allergens most frequently recognized by IgE were Phl p 1 (33.8%),</s><s>Phl p 4 (22.4%),</s><s>Ole e 1 (20.9%),</s><s>Phl p 5 (18.2%),</s><s>Cup a 1 (18.2%),</s><s>Phl p 2 (15.3%),</s><s>Phl p 6 (14.4%), and Bet v 1 (10%) (Table II).</s><s>The indoor allergens most frequently recognized by IgE were Der p 2 (27.4%),</s><s>Der p 23 (27.4%),</s><s>Der p 1 (24.4%),</s><s>Fel d 1 (23.8%),</s><s>Der p 5 (16.5%),</s><s>Der p 4 (15.9%),</s><s>Der p 7 (13.2%),</s><s>Can f 5 (11.2%), and Der p 21 (10%) (Table</s></p></div></figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>TABLE I .</head><label>I</label><figDesc><div><p><s>Description of the study population (n 5 340)</s></p></div></figDesc><table><row><cell>Characteristic</cell><cell>n (%)/mean 6 SD</cell></row><row><cell>Sex: Male</cell><cell>159 (46.8)</cell></row><row><cell>Age (y)</cell><cell>43.4 6 16.8</cell></row><row><cell>Status at recruitment</cell><cell></cell></row><row><cell>Asthma cases</cell><cell>83 (24.4)</cell></row><row><cell>First-degree relatives of cases</cell><cell>184 (54.1)</cell></row><row><cell>Controls</cell><cell>73 (21.5)</cell></row><row><cell>Recruitment center</cell><cell></cell></row><row><cell>Paris</cell><cell>96 (28.2)</cell></row><row><cell>Lyon</cell><cell>75 (22.1)</cell></row><row><cell>Marseille</cell><cell>41 (12.0)</cell></row><row><cell>Montpellier</cell><cell>22 (6.5)</cell></row><row><cell>Grenoble</cell><cell>106 (31.2)</cell></row><row><cell>Asthma ever</cell><cell>170 (50)</cell></row><row><cell>Asthma in the past 12 mo</cell><cell>138 (87.3)</cell></row><row><cell>Allergic sensitization (&gt; _1 positive SPT</cell><cell>197 (57.9)</cell></row><row><cell>among the 11 allergen sources)*</cell><cell></cell></row><row><cell>Total IgE &gt; 100 IU/mL</cell><cell>145 (42.7)</cell></row><row><cell>Allergic rhinitis ever</cell><cell>176 (52.4)</cell></row><row><cell>Allergic rhinitis in the past 12 mo</cell><cell>138 (44.8)</cell></row><row><cell>Blood eosinophil counts &gt;250 mm 3</cell><cell>86 (25.4)</cell></row><row><cell>Atopic dermatitis ever</cell><cell>127 (37.6)</cell></row><row><cell>FEV 1 &lt;80% of predicted value</cell><cell>46 (13.6)</cell></row><row><cell>Combined asthma (ever) and allergic rhinitis</cell><cell></cell></row><row><cell>(ever) phenotypes</cell><cell></cell></row><row><cell>No asthma and no rhinitis</cell><cell>121 (31.0)</cell></row><row><cell>No asthma but rhinitis</cell><cell>48 (14.3)</cell></row><row><cell>Asthma but no rhinitis</cell><cell>39 (11.6)</cell></row><row><cell>Asthma and rhinitis</cell><cell>128 (38.1)</cell></row></table><note><p><s>*The 11 allergen sources were cat, Dermatophagoides pteronyssinus, Blattella germanica, olive, birch, Parietaria judaica, timothy grass, ragweed, Aspergillus, Cladosporium herbarum, and Alternaria tenuis.The threshold of 100 IU/mL has been used as in many other studies.ragweedexposure:Amba1;grasspollen</s><s>exposure: Phl p 1; and exposure to cypress: Cup a 1) (Fig 1 and TableIII).For example, in agreement with similar levels of grass pollen exposure across France, IgE recognition frequencies for the major timothy grass pollen allergen, Phl p 1, were similar across the geographical areas (the adjusted odds ratios for each center as compared with Paris varied between 0.68 and 1.29; P &gt; .50;TableIII)andIgG</s><s>recognition of Phl p 1 was higher than 90% in each area.Inversely, IgE and IgG recognition frequencies for the cypress pollen allergen Cup a 1 showed marked geographical differences, with adjusted odds ratio of 7.4 (95% CI, 2.1-25.3)and7.8</s><s>(95% CI, 0.98-62.2) in Montpellier, the city showing the highest level of pollen exposures, as compared with Paris.Similar patterns were observed in subjects with and in subjects without asthma (see TableE3in this article's Online Repository at www.jacionline.org),</s><s>as well as in subjects</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>TABLE II .</head><label>II</label><figDesc><div><p><s>Allergen-specific IgE and IgG description Fel d, Felis domesticus; Mal d, Malus domestica.</s><s>without AIT (see Table E4 in this article's Online Repository at www.jacionline.org),</s><s>although results should be interpreted cautiously because of the sample size.</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell cols="2">In all (n 5 340)</cell><cell></cell><cell></cell><cell cols="2">In subjects without AIT (n 5 258)</cell><cell></cell></row><row><cell></cell><cell></cell><cell cols="2">IgE &gt; _ 0.3 ISU</cell><cell cols="2">IgG &gt; _ 0.5 ISU</cell><cell cols="2">IgE &gt; _ 0.3 ISU</cell><cell cols="2">IgG &gt; _ 0.5 ISU</cell></row><row><cell>Allergen source</cell><cell>Allergen</cell><cell>n</cell><cell>%</cell><cell>n</cell><cell>%</cell><cell>n</cell><cell>%</cell><cell>n</cell><cell>%</cell></row><row><cell>Inhaled allergens</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Birch</cell><cell>rBet v 1</cell><cell>34</cell><cell>10.0</cell><cell>225</cell><cell>66.6</cell><cell>18</cell><cell>7.0</cell><cell>165</cell><cell>64.2</cell></row><row><cell></cell><cell>rBet v 4</cell><cell>13</cell><cell>3.8</cell><cell>109</cell><cell>32.2</cell><cell>3</cell><cell>1.2</cell><cell>79</cell><cell>30.7</cell></row><row><cell></cell><cell>rBet v 2</cell><cell>10</cell><cell>2.9</cell><cell>288</cell><cell>85.2</cell><cell>3</cell><cell>1.2</cell><cell>218</cell><cell>84.8</cell></row><row><cell>Olive</cell><cell>rOle e 1</cell><cell>71</cell><cell>20.9</cell><cell>220</cell><cell>65.1</cell><cell>39</cell><cell>15.1</cell><cell>157</cell><cell>61.1</cell></row><row><cell></cell><cell>nOle e 7</cell><cell>5</cell><cell>1.5</cell><cell>67</cell><cell>19.8</cell><cell>2</cell><cell>0.8</cell><cell>46</cell><cell>17.9</cell></row><row><cell></cell><cell>rOle e 9</cell><cell>2</cell><cell>0.6</cell><cell>338</cell><cell>100.0</cell><cell>1</cell><cell>0.4</cell><cell>257</cell><cell>100.0</cell></row><row><cell>Cypress</cell><cell>nCup a 1</cell><cell>62</cell><cell>18.2</cell><cell>255</cell><cell>75.4</cell><cell>32</cell><cell>12.4</cell><cell>193</cell><cell>75.1</cell></row><row><cell>Timothy grass</cell><cell>rPhl p 1</cell><cell>115</cell><cell>33.8</cell><cell>322</cell><cell>95.3</cell><cell>67</cell><cell>26.0</cell><cell>244</cell><cell>94.9</cell></row><row><cell></cell><cell>rPhl p 2</cell><cell>52</cell><cell>15.3</cell><cell>115</cell><cell>34.0</cell><cell>25</cell><cell>9.7</cell><cell>76</cell><cell>29.6</cell></row><row><cell></cell><cell>nPhl p 4</cell><cell>76</cell><cell>22.4</cell><cell>282</cell><cell>83.4</cell><cell>35</cell><cell>13.6</cell><cell>209</cell><cell>81.3</cell></row><row><cell></cell><cell>rPhl p 5</cell><cell>62</cell><cell>18.2</cell><cell>218</cell><cell>64.5</cell><cell>23</cell><cell>8.9</cell><cell>161</cell><cell>62.6</cell></row><row><cell></cell><cell>rPhl p 6</cell><cell>49</cell><cell>14.4</cell><cell>229</cell><cell>67.8</cell><cell>20</cell><cell>7.8</cell><cell>169</cell><cell>65.8</cell></row><row><cell></cell><cell>rPhl p 7</cell><cell>13</cell><cell>3.8</cell><cell>94</cell><cell>27.8</cell><cell>3</cell><cell>1.2</cell><cell>68</cell><cell>26.5</cell></row><row><cell></cell><cell>rPhl p 11</cell><cell>23</cell><cell>6.8</cell><cell>133</cell><cell>39.3</cell><cell>7</cell><cell>2.7</cell><cell>93</cell><cell>36.2</cell></row><row><cell></cell><cell>rPhl p 12</cell><cell>6</cell><cell>1.8</cell><cell>310</cell><cell>91.7</cell><cell>0</cell><cell>0.0</cell><cell>236</cell><cell>91.8</cell></row><row><cell>Ragweed</cell><cell>nAmb a 1</cell><cell>13</cell><cell>3.8</cell><cell>109</cell><cell>32.2</cell><cell>8</cell><cell>3.1</cell><cell>81</cell><cell>31.5</cell></row><row><cell>House dust mite</cell><cell>nDer p 1</cell><cell>83</cell><cell>24.4</cell><cell>317</cell><cell>93.8</cell><cell>43</cell><cell>16.7</cell><cell>238</cell><cell>92.6</cell></row><row><cell></cell><cell>rDer p 2</cell><cell>93</cell><cell>27.4</cell><cell>278</cell><cell>82.2</cell><cell>49</cell><cell>19.0</cell><cell>206</cell><cell>80.2</cell></row><row><cell></cell><cell>rDer p 4</cell><cell>54</cell><cell>15.9</cell><cell>142</cell><cell>42.0</cell><cell>27</cell><cell>10.5</cell><cell>102</cell><cell>39.7</cell></row><row><cell></cell><cell>rDer p 5</cell><cell>56</cell><cell>16.5</cell><cell>321</cell><cell>95.0</cell><cell>23</cell><cell>8.9</cell><cell>246</cell><cell>95.7</cell></row><row><cell></cell><cell>rDer p 7</cell><cell>45</cell><cell>13.2</cell><cell>301</cell><cell>89.1</cell><cell>16</cell><cell>6.2</cell><cell>228</cell><cell>88.7</cell></row><row><cell></cell><cell>rDer p 10</cell><cell>31</cell><cell>9.1</cell><cell>214</cell><cell>63.3</cell><cell>13</cell><cell>5.0</cell><cell>156</cell><cell>60.7</cell></row><row><cell></cell><cell>rDer p 11</cell><cell>15</cell><cell>4.4</cell><cell>331</cell><cell>97.9</cell><cell>6</cell><cell>2.3</cell><cell>251</cell><cell>97.7</cell></row><row><cell></cell><cell>rDer p 14</cell><cell>7</cell><cell>2.1</cell><cell>334</cell><cell>98.8</cell><cell>2</cell><cell>0.8</cell><cell>254</cell><cell>98.8</cell></row><row><cell></cell><cell>rDer p 15</cell><cell>15</cell><cell>4.4</cell><cell>327</cell><cell>96.7</cell><cell>6</cell><cell>2.3</cell><cell>249</cell><cell>96.9</cell></row><row><cell></cell><cell>rDer p 18</cell><cell>17</cell><cell>5.0</cell><cell>328</cell><cell>97.0</cell><cell>4</cell><cell>1.6</cell><cell>250</cell><cell>97.3</cell></row><row><cell></cell><cell>rDer p 21</cell><cell>34</cell><cell>10.0</cell><cell>334</cell><cell>98.8</cell><cell>14</cell><cell>5.4</cell><cell>255</cell><cell>99.2</cell></row><row><cell></cell><cell>rDer p 23</cell><cell>93</cell><cell>27.4</cell><cell>335</cell><cell>99.1</cell><cell>50</cell><cell>19.4</cell><cell>255</cell><cell>99.2</cell></row><row><cell></cell><cell>rClone 16</cell><cell>33</cell><cell>9.7</cell><cell>292</cell><cell>86.4</cell><cell>12</cell><cell>4.7</cell><cell>218</cell><cell>84.8</cell></row><row><cell>Cat</cell><cell>rFel d 1</cell><cell>81</cell><cell>23.8</cell><cell>306</cell><cell>90.5</cell><cell>41</cell><cell>15.9</cell><cell>233</cell><cell>90.7</cell></row><row><cell></cell><cell>nFel d 2</cell><cell>25</cell><cell>7.4</cell><cell>179</cell><cell>53.0</cell><cell>12</cell><cell>4.7</cell><cell>130</cell><cell>50.6</cell></row><row><cell></cell><cell>rFel d 4</cell><cell>18</cell><cell>5.3</cell><cell>253</cell><cell>74.9</cell><cell>6</cell><cell>2.3</cell><cell>192</cell><cell>74.7</cell></row><row><cell>Dog</cell><cell>rCan f 1</cell><cell>22</cell><cell>6.5</cell><cell>202</cell><cell>59.8</cell><cell>7</cell><cell>2.7</cell><cell>152</cell><cell>59.1</cell></row><row><cell></cell><cell>rCan f 2</cell><cell>8</cell><cell>2.4</cell><cell>188</cell><cell>55.6</cell><cell>2</cell><cell>0.8</cell><cell>139</cell><cell>54.1</cell></row><row><cell></cell><cell>nCan f 3</cell><cell>8</cell><cell>2.4</cell><cell>164</cell><cell>48.5</cell><cell>3</cell><cell>1.2</cell><cell>121</cell><cell>47.1</cell></row><row><cell></cell><cell>rCan f 4</cell><cell>16</cell><cell>4.7</cell><cell>296</cell><cell>87.6</cell><cell>2</cell><cell>0.8</cell><cell>228</cell><cell>88.7</cell></row><row><cell></cell><cell>rCan f 5</cell><cell>38</cell><cell>11.2</cell><cell>265</cell><cell>78.4</cell><cell>18</cell><cell>7.0</cell><cell>198</cell><cell>77.0</cell></row><row><cell></cell><cell>rCan f 6</cell><cell>16</cell><cell>4.7</cell><cell>277</cell><cell>82.0</cell><cell>6</cell><cell>2.3</cell><cell>212</cell><cell>82.5</cell></row><row><cell>Food allergens</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Apple</cell><cell>rMal d 1</cell><cell>26</cell><cell>7.6</cell><cell>284</cell><cell>84.0</cell><cell>14</cell><cell>5.4</cell><cell>216</cell><cell>84.0</cell></row><row><cell>Hazelnut</cell><cell>rCor a 1.0401</cell><cell>24</cell><cell>7.1</cell><cell>234</cell><cell>69.2</cell><cell>12</cell><cell>4.7</cell><cell>176</cell><cell>68.5</cell></row><row><cell>Peanut</cell><cell>rAra h 8</cell><cell>16</cell><cell>4.7</cell><cell>233</cell><cell>68.9</cell><cell>6</cell><cell>2.3</cell><cell>180</cell><cell>70.0</cell></row><row><cell>Peach</cell><cell>rPru p 1</cell><cell>20</cell><cell>5.9</cell><cell>242</cell><cell>71.6</cell><cell>10</cell><cell>3.9</cell><cell>180</cell><cell>70.0</cell></row><row><cell>Soy</cell><cell>rGly m 4</cell><cell>8</cell><cell>2.4</cell><cell>292</cell><cell>86.4</cell><cell>2</cell><cell>0.8</cell><cell>221</cell><cell>86.0</cell></row><row><cell>Milk</cell><cell>nBos d 4</cell><cell>1</cell><cell>0.3</cell><cell>299</cell><cell>88.5</cell><cell>1</cell><cell>0.4</cell><cell>232</cell><cell>90.3</cell></row><row><cell></cell><cell>nBos d 8</cell><cell>0</cell><cell>0.0</cell><cell>309</cell><cell>91.4</cell><cell>0</cell><cell>0.0</cell><cell>234</cell><cell>91.1</cell></row><row><cell>Egg</cell><cell>nGal d 1</cell><cell>2</cell><cell>0.6</cell><cell>289</cell><cell>85.5</cell><cell>0</cell><cell>0.0</cell><cell>217</cell><cell>84.4</cell></row><row><cell>Codfish</cell><cell>rGad c 1</cell><cell>0</cell><cell>0.0</cell><cell>95</cell><cell>28.1</cell><cell>0</cell><cell>0.0</cell><cell>72</cell><cell>28.0</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>TABLE III .</head><label>III</label><figDesc><div><p><s>Adjusted ORs* for different centers of recruitment for being IgE-or IgG-positive to different airborne allergens Some ORs could not be estimated because of sample size (represented by -in the table).</s><s>ORs associated with a P value of &lt;.05 are presented in boldface.</s><s>OR, Odds ratio.</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>IgE (&lt;0.3; &gt; _0.3)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>IgG (&lt;0.5; &gt; _0.5)</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>Lower</cell><cell>Upper</cell><cell>P</cell><cell>Global</cell><cell></cell><cell>Lower</cell><cell>Upper</cell><cell>P</cell><cell>Global</cell></row><row><cell>Allergen</cell><cell>Center</cell><cell>OR</cell><cell>95% CI</cell><cell>95% CI</cell><cell>value</cell><cell>P value</cell><cell>OR</cell><cell>95% CI</cell><cell>95% CI</cell><cell>value</cell><cell>P value</cell></row><row><cell>Amb a 1</cell><cell>Lyon</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>3.56</cell><cell>1.81</cell><cell>7.02</cell><cell>&lt;.01</cell><cell>.001</cell></row><row><cell></cell><cell>Marseille</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>2.52</cell><cell>1.09</cell><cell>5.85</cell><cell>.03</cell><cell></cell></row><row><cell></cell><cell>Montpellier</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>0.79</cell><cell>0.23</cell><cell>2.67</cell><cell>.70</cell><cell></cell></row><row><cell></cell><cell>Grenoble</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>1.32</cell><cell>0.69</cell><cell>2.51</cell><cell>.40</cell><cell></cell></row><row><cell>Bet v 1</cell><cell>Lyon</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>1.57</cell><cell>0.8</cell><cell>3.09</cell><cell>.19</cell><cell>.5</cell></row><row><cell></cell><cell>Marseille</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>1.64</cell><cell>0.7</cell><cell>3.83</cell><cell>.26</cell><cell></cell></row><row><cell></cell><cell>Montpellier</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>0.93</cell><cell>0.34</cell><cell>2.54</cell><cell>.88</cell><cell></cell></row><row><cell></cell><cell>Grenoble</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>1.53</cell><cell>0.83</cell><cell>2.83</cell><cell>.17</cell><cell></cell></row><row><cell>Cup a 1</cell><cell>Lyon</cell><cell>0.67</cell><cell>0.24</cell><cell>1.84</cell><cell>.44</cell><cell>.0009</cell><cell>1.38</cell><cell>0.66</cell><cell>2.87</cell><cell>.39</cell><cell>.29</cell></row><row><cell></cell><cell>Marseille</cell><cell>3.56</cell><cell>1.17</cell><cell>10.9</cell><cell>.03</cell><cell></cell><cell>1.7</cell><cell>0.64</cell><cell>4.49</cell><cell>.29</cell><cell></cell></row><row><cell></cell><cell>Montpellier</cell><cell>7.37</cell><cell>2.15</cell><cell>25.3</cell><cell>&lt;.01</cell><cell></cell><cell>7.79</cell><cell>0.98</cell><cell>62.2</cell><cell>.05</cell><cell></cell></row><row><cell></cell><cell>Grenoble</cell><cell>0.85</cell><cell>0.36</cell><cell>1.96</cell><cell>.7</cell><cell></cell><cell>1.05</cell><cell>0.56</cell><cell>1.96</cell><cell>.88</cell><cell></cell></row><row><cell>Phl p 1</cell><cell>Lyon</cell><cell>0.81</cell><cell>0.36</cell><cell>1.83</cell><cell>.61</cell><cell>.69</cell><cell>4.87</cell><cell>0.57</cell><cell>41.7</cell><cell>.15</cell><cell>-</cell></row><row><cell></cell><cell>Marseille</cell><cell>1.29</cell><cell>0.47</cell><cell>3.58</cell><cell>.62</cell><cell></cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Montpellier</cell><cell>0.68</cell><cell>0.2</cell><cell>2.26</cell><cell>.52</cell><cell></cell><cell>1.28</cell><cell>0.14</cell><cell>11.9</cell><cell>.83</cell><cell></cell></row><row><cell></cell><cell>Grenoble</cell><cell>1.28</cell><cell>0.63</cell><cell>2.6</cell><cell>.5</cell><cell></cell><cell>1.33</cell><cell>0.42</cell><cell>4.2</cell><cell>.62</cell><cell></cell></row><row><cell>Der p 1</cell><cell>Lyon</cell><cell>0.37</cell><cell>0.15</cell><cell>0.96</cell><cell>.04</cell><cell>.01</cell><cell>13.6</cell><cell>1.68</cell><cell>110</cell><cell>.01</cell><cell>-</cell></row><row><cell></cell><cell>Marseille</cell><cell>0.28</cell><cell>0.07</cell><cell>1.12</cell><cell>.07</cell><cell></cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Montpellier</cell><cell>1.00</cell><cell>0.28</cell><cell>3.58</cell><cell>.99</cell><cell></cell><cell>0.81</cell><cell>0.21</cell><cell>3.08</cell><cell>.76</cell><cell></cell></row><row><cell></cell><cell>Grenoble</cell><cell>1.53</cell><cell>0.75</cell><cell>3.11</cell><cell>.24</cell><cell></cell><cell>4.22</cell><cell>1.28</cell><cell>13.9</cell><cell>.02</cell><cell></cell></row><row><cell>Der p 2</cell><cell>Lyon</cell><cell>0.32</cell><cell>0.13</cell><cell>0.81</cell><cell>.02</cell><cell>.004</cell><cell>2.48</cell><cell>1.05</cell><cell>5.85</cell><cell>.04</cell><cell>.12</cell></row><row><cell></cell><cell>Marseille</cell><cell>0.41</cell><cell>0.13</cell><cell>1.36</cell><cell>.15</cell><cell></cell><cell>1.42</cell><cell>0.54</cell><cell>3.73</cell><cell>.48</cell><cell></cell></row><row><cell></cell><cell>Montpellier</cell><cell>0.91</cell><cell>0.27</cell><cell>3.07</cell><cell>.88</cell><cell></cell><cell>7.1</cell><cell>0.86</cell><cell>58.7</cell><cell>.07</cell><cell></cell></row><row><cell></cell><cell>Grenoble</cell><cell>1.67</cell><cell>0.83</cell><cell>3.38</cell><cell>.15</cell><cell></cell><cell>1.87</cell><cell>0.89</cell><cell>3.9</cell><cell>.1</cell><cell></cell></row></table><note><p><s>*OR (reference: Paris) adjusted for age, sex, asthma status, and rhinitis status.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>TABLE E1 .</head><label>E1</label><figDesc><div><p><s>Comparison of included and excluded subjects</s></p></div></figDesc><table><row><cell></cell><cell cols="2">Subjects without asthma</cell><cell></cell><cell cols="2">Subjects with asthma</cell><cell></cell></row><row><cell>Characteristic</cell><cell>Excluded</cell><cell>Included</cell><cell>P value</cell><cell>Excluded</cell><cell>Included</cell><cell>P value</cell></row><row><cell>n</cell><cell>697</cell><cell>170</cell><cell></cell><cell>507</cell><cell>170</cell><cell></cell></row><row><cell>Age (y), mean 6 SD</cell><cell>46.3 6 16.0</cell><cell>46.8 6 16.7</cell><cell>.68</cell><cell>38.8 6 16.8</cell><cell>40.0 6 16.4</cell><cell>.42</cell></row><row><cell>Sex, % males</cell><cell>46.6</cell><cell>47.7</cell><cell>.81</cell><cell>49.1</cell><cell>41.2</cell><cell>.07</cell></row><row><cell>Center of recruitment, %</cell><cell></cell><cell></cell><cell>.51</cell><cell></cell><cell></cell><cell>.02</cell></row><row><cell>Paris</cell><cell>26.7</cell><cell>27.7</cell><cell></cell><cell>35.1</cell><cell>28.8</cell><cell></cell></row><row><cell>Lyon</cell><cell>17.9</cell><cell>22.9</cell><cell></cell><cell>13.0</cell><cell>21.2</cell><cell></cell></row><row><cell>Marseille</cell><cell>17.8</cell><cell>14.1</cell><cell></cell><cell>16.4</cell><cell>10.0</cell><cell></cell></row><row><cell>Montpellier</cell><cell>7.0</cell><cell>5.9</cell><cell></cell><cell>8.1</cell><cell>7.1</cell><cell></cell></row><row><cell>Grenoble</cell><cell>30.6</cell><cell>29.4</cell><cell></cell><cell>27.4</cell><cell>32.9</cell><cell></cell></row><row><cell>Cat ownership,* %</cell><cell>53.2</cell><cell>48.2</cell><cell>.24</cell><cell>49.1</cell><cell>52.9</cell><cell>.39</cell></row><row><cell>Allergic rhinitis ever</cell><cell>30.2</cell><cell>28.4</cell><cell>.65</cell><cell>70.1</cell><cell>76.7</cell><cell>.10</cell></row><row><cell>Allergic sensitization (&gt; _1 SPT among 12 allergens), %</cell><cell>38.9</cell><cell>34.7</cell><cell>.33</cell><cell>76.3</cell><cell>81.2</cell><cell>.20</cell></row><row><cell>Total IgE &gt;100 IU/mL, %</cell><cell>30.7</cell><cell>24.7</cell><cell>.13</cell><cell>59.2</cell><cell>60.6</cell><cell>.75</cell></row></table><note><p><s>*Current cat ownership or in childhood.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_6"><head>TABLE E2 .</head><label>E2</label><figDesc><div><p><s>Agreement between SPT and allergen-specific IgE for those 7 allergen sources that showed a prevalence of &gt;5% for positive SPT result in the study population</s></p></div></figDesc><table><row><cell></cell><cell>No. of components</cell><cell></cell><cell>Allergen-specific IgE &gt; _0.3 ISU for at least 1</cell><cell></cell></row><row><cell>Allergen source</cell><cell>on the MeDALL chip</cell><cell>Positive SPT, %</cell><cell>of the allergen components, %</cell><cell>Cohen kappa coefficient</cell></row><row><cell>Timothy grass</cell><cell>8</cell><cell>33.5</cell><cell>39.4</cell><cell>0.76</cell></row><row><cell>House dust mite</cell><cell>15</cell><cell>33.5</cell><cell>34.7</cell><cell>0.83</cell></row><row><cell>Cat</cell><cell>3</cell><cell>21.8</cell><cell>23.8</cell><cell>0.76</cell></row><row><cell>Olive</cell><cell>3</cell><cell>20.6</cell><cell>21.2</cell><cell>0.79</cell></row><row><cell>Birch</cell><cell>3</cell><cell>10.6</cell><cell>13.8</cell><cell>0.71</cell></row><row><cell>Alternaria</cell><cell>2</cell><cell>8.8</cell><cell>9.4</cell><cell>0.65</cell></row><row><cell>Ragweed</cell><cell>1</cell><cell>5.9</cell><cell>3.8</cell><cell>0.71</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_7"><head>TABLE E3 .</head><label>E3</label><figDesc><div><p><s>Unadjusted ORs for different centers of recruitment for being IgE-or IgG-positive to different airborne allergens (reference: Paris), by asthma status</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="4">In subjects without asthma (n 5 170)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="4">In subjects with asthma (n 5 170)</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell cols="2">IgE (&lt;0.3; &gt; _0.3)</cell><cell></cell><cell></cell><cell cols="2">IgG (&lt;0.5; &gt; _0.5)</cell><cell></cell><cell></cell><cell cols="2">IgE (&lt;0.3; &gt; _0.3)</cell><cell></cell><cell></cell><cell cols="2">IgG (&lt;0.5; &gt; _0.5)</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>Lower</cell><cell>Upper</cell><cell>P</cell><cell></cell><cell>Lower</cell><cell>Upper</cell><cell>P</cell><cell></cell><cell>Lower</cell><cell>Upper</cell><cell>P</cell><cell></cell><cell>Lower</cell><cell>Upper</cell><cell>P</cell></row><row><cell>Allergen</cell><cell>Center</cell><cell>OR</cell><cell>95% CI</cell><cell>95% CI</cell><cell>value</cell><cell>OR</cell><cell>95% CI</cell><cell>95% CI</cell><cell>value</cell><cell>OR</cell><cell>95% CI</cell><cell>95% CI</cell><cell>value</cell><cell>OR</cell><cell>95%CI</cell><cell>95% CI</cell><cell>value</cell></row><row><cell>Amb a 1</cell><cell>Lyon</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell>2.25</cell><cell>0.91</cell><cell>5.61</cell><cell>.08</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell>5.46</cell><cell>2.09</cell><cell>14.3</cell><cell>&lt;.01</cell></row><row><cell></cell><cell>Marseille</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell>1.46</cell><cell>0.5</cell><cell>4.26</cell><cell>.49</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell>3.9</cell><cell>1.17</cell><cell>13</cell><cell>.03</cell></row><row><cell></cell><cell>Montpellier</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell>1.25</cell><cell>0.28</cell><cell>5.62</cell><cell>.77</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell>0.35</cell><cell>0.04</cell><cell>3.08</cell><cell>.35</cell></row><row><cell></cell><cell>Grenoble</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell>1.17</cell><cell>0.47</cell><cell>2.88</cell><cell>.74</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell>1.43</cell><cell>0.57</cell><cell>3.55</cell><cell>.45</cell></row><row><cell>Bet v 1</cell><cell>Lyon</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell>1.57</cell><cell>0.66</cell><cell>3.75</cell><cell>.31</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell>1.08</cell><cell>0.4</cell><cell>2.9</cell><cell>.87</cell></row><row><cell></cell><cell>Marseille</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell>1.23</cell><cell>0.46</cell><cell>3.33</cell><cell>.68</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell>0.79</cell><cell>0.23</cell><cell>2.73</cell><cell>.71</cell></row><row><cell></cell><cell>Montpellier</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell>0.88</cell><cell>0.22</cell><cell>3.45</cell><cell>.85</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell>0.72</cell><cell>0.19</cell><cell>2.81</cell><cell>.64</cell></row><row><cell></cell><cell>Grenoble</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell>1.66</cell><cell>0.73</cell><cell>3.77</cell><cell>.23</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell>1.08</cell><cell>0.45</cell><cell>2.6</cell><cell>.86</cell></row><row><cell>Cup a 1</cell><cell>Lyon</cell><cell>0.59</cell><cell>0.05</cell><cell>6.79</cell><cell>.67</cell><cell>2.36</cell><cell>0.85</cell><cell>6.52</cell><cell>.1</cell><cell>0.55</cell><cell>0.2</cell><cell>1.52</cell><cell>.25</cell><cell>0.97</cell><cell>0.36</cell><cell>2.64</cell><cell>.96</cell></row><row><cell></cell><cell>Marseille</cell><cell>3.21</cell><cell>0.5</cell><cell>20.7</cell><cell>.22</cell><cell>1.96</cell><cell>0.62</cell><cell>6.23</cell><cell>.25</cell><cell>2.55</cell><cell>0.82</cell><cell>7.89</cell><cell>.1</cell><cell>2.27</cell><cell>0.45</cell><cell>11.5</cell><cell>.32</cell></row><row><cell></cell><cell>Montpellier</cell><cell>15</cell><cell>2.25</cell><cell>100</cell><cell>.01</cell><cell>2.06</cell><cell>0.39</cell><cell>10.9</cell><cell>.39</cell><cell>2.27</cell><cell>0.63</cell><cell>8.19</cell><cell>.21</cell><cell>-</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Grenoble</cell><cell>0.94</cell><cell>0.13</cell><cell>6.94</cell><cell>.95</cell><cell>1.43</cell><cell>0.6</cell><cell>3.43</cell><cell>.42</cell><cell>0.69</cell><cell>0.29</cell><cell>1.63</cell><cell>.39</cell><cell>0.74</cell><cell>0.31</cell><cell>1.77</cell><cell>.5</cell></row><row><cell>Phl p 1</cell><cell>Lyon</cell><cell>0.56</cell><cell>0.15</cell><cell>2.01</cell><cell>.37</cell><cell>2.59</cell><cell>0.26</cell><cell>26</cell><cell>.42</cell><cell>0.88</cell><cell>0.37</cell><cell>2.09</cell><cell>.78</cell><cell>-</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Marseille</cell><cell>0.98</cell><cell>0.26</cell><cell>3.63</cell><cell>.97</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell>1</cell><cell>0.33</cell><cell>3.01</cell><cell>.99</cell><cell>-</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Montpellier</cell><cell>3.25</cell><cell>0.74</cell><cell>14.2</cell><cell>.12</cell><cell>0.61</cell><cell>0.06</cell><cell>6.59</cell><cell>.69</cell><cell>0.18</cell><cell>0.04</cell><cell>0.89</cell><cell>.04</cell><cell>0.98</cell><cell>0.1</cell><cell>9.64</cell><cell>.98</cell></row><row><cell></cell><cell>Grenoble</cell><cell>1.22</cell><cell>0.44</cell><cell>3.41</cell><cell>.71</cell><cell>1.6</cell><cell>0.26</cell><cell>10</cell><cell>.61</cell><cell>1.02</cell><cell>0.47</cell><cell>2.2</cell><cell>.96</cell><cell>1.16</cell><cell>0.27</cell><cell>4.89</cell><cell>.84</cell></row><row><cell>Der p 1</cell><cell>Lyon</cell><cell>0.45</cell><cell>0.08</cell><cell>2.48</cell><cell>.36</cell><cell>7.79</cell><cell>0.93</cell><cell>65.4</cell><cell>.06</cell><cell>0.32</cell><cell>0.12</cell><cell>0.85</cell><cell>.02</cell><cell>-</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Marseille</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell>0.35</cell><cell>0.1</cell><cell>1.22</cell><cell>.1</cell><cell>-</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Montpellier</cell><cell>0.93</cell><cell>0.1</cell><cell>8.99</cell><cell>.95</cell><cell>1.85</cell><cell>0.2</cell><cell>16.7</cell><cell>.59</cell><cell>0.57</cell><cell>0.15</cell><cell>2.13</cell><cell>.4</cell><cell>0.27</cell><cell>0.05</cell><cell>1.4</cell><cell>.12</cell></row><row><cell></cell><cell>Grenoble</cell><cell>0.73</cell><cell>0.18</cell><cell>2.9</cell><cell>.66</cell><cell>4.82</cell><cell>0.97</cell><cell>24</cell><cell>.06</cell><cell>1.51</cell><cell>0.7</cell><cell>3.26</cell><cell>.3</cell><cell>2.4</cell><cell>0.42</cell><cell>13.7</cell><cell>.32</cell></row><row><cell>Der p 2</cell><cell>Lyon</cell><cell>0.45</cell><cell>0.08</cell><cell>2.48</cell><cell>.36</cell><cell>2.14</cell><cell>0.77</cell><cell>5.96</cell><cell>.14</cell><cell>0.27</cell><cell>0.1</cell><cell>0.72</cell><cell>.01</cell><cell>2.15</cell><cell>0.53</cell><cell>8.74</cell><cell>.29</cell></row><row><cell></cell><cell>Marseille</cell><cell>0.76</cell><cell>0.14</cell><cell>4.26</cell><cell>.76</cell><cell>1.14</cell><cell>0.39</cell><cell>3.33</cell><cell>.81</cell><cell>0.4</cell><cell>0.12</cell><cell>1.31</cell><cell>.13</cell><cell>1.37</cell><cell>0.26</cell><cell>7.21</cell><cell>.71</cell></row><row><cell></cell><cell>Montpellier</cell><cell>0.93</cell><cell>0.1</cell><cell>8.99</cell><cell>.95</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell>0.69</cell><cell>0.19</cell><cell>2.46</cell><cell>.56</cell><cell>2.15</cell><cell>0.24</cell><cell>19</cell><cell>.49</cell></row><row><cell></cell><cell>Grenoble</cell><cell>1.15</cell><cell>0.32</cell><cell>4.04</cell><cell>.83</cell><cell>1.62</cell><cell>0.65</cell><cell>4.02</cell><cell>.3</cell><cell>1.48</cell><cell>0.68</cell><cell>3.22</cell><cell>.32</cell><cell>1.63</cell><cell>0.52</cell><cell>5.06</cell><cell>.4</cell></row><row><cell>OR, Odds ratio.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_8"><head>TABLE E4 .</head><label>E4</label><figDesc><div><p><s>Adjusted ORs* for different centers of recruitment for being IgE-or IgG-positive to different allergens (reference: Paris) among subjects without AIT Some ORs could not be estimated because of sample size (represented by -in the table).</s><s>ORs associated with a P value of &lt; _.05 are presented in boldface.</s><s>OR, Odds ratio.</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell cols="2">IgE (&lt;0.3; &gt; _0.3)</cell><cell></cell><cell></cell><cell cols="2">IgG (&lt;0.5; &gt; _0.5)</cell><cell></cell></row><row><cell>Allergen</cell><cell>Center</cell><cell>OR</cell><cell>Lower 95% CI</cell><cell>Upper 95% CI</cell><cell>P value</cell><cell>OR</cell><cell>Lower 95% CI</cell><cell>Upper 95% CI</cell><cell>P value</cell></row><row><cell>Amb a 1</cell><cell>Lyon</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell>2.60</cell><cell>1.20</cell><cell>5.65</cell><cell>.02</cell></row><row><cell></cell><cell>Marseille</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell>1.92</cell><cell>0.73</cell><cell>5.03</cell><cell>.18</cell></row><row><cell></cell><cell>Montpellier</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell>0.79</cell><cell>0.19</cell><cell>3.25</cell><cell>.74</cell></row><row><cell></cell><cell>Grenoble</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell>1.15</cell><cell>0.55</cell><cell>2.42</cell><cell>.72</cell></row><row><cell>Bet v 1</cell><cell>Lyon</cell><cell>0.42</cell><cell>0.08</cell><cell>2.19</cell><cell>.30</cell><cell>1.77</cell><cell>0.81</cell><cell>3.85</cell><cell>.15</cell></row><row><cell></cell><cell>Marseille</cell><cell>-</cell><cell></cell><cell></cell><cell>.95</cell><cell>1.60</cell><cell>0.62</cell><cell>4.13</cell><cell>.34</cell></row><row><cell></cell><cell>Montpellier</cell><cell>-</cell><cell></cell><cell></cell><cell>.97</cell><cell>0.50</cell><cell>0.15</cell><cell>1.64</cell><cell>.25</cell></row><row><cell></cell><cell>Grenoble</cell><cell>0.87</cell><cell>0.25</cell><cell>2.98</cell><cell>.82</cell><cell>1.34</cell><cell>0.67</cell><cell>2.69</cell><cell>.40</cell></row><row><cell>Cup a 1</cell><cell>Lyon</cell><cell>0.51</cell><cell>0.10</cell><cell>2.58</cell><cell>.42</cell><cell>1.35</cell><cell>0.58</cell><cell>3.16</cell><cell>.48</cell></row><row><cell></cell><cell>Marseille</cell><cell>4.64</cell><cell>0.99</cell><cell>21.70</cell><cell>.05</cell><cell>1.71</cell><cell>0.55</cell><cell>5.36</cell><cell>.36</cell></row><row><cell></cell><cell>Montpellier</cell><cell>13.79</cell><cell>2.64</cell><cell>72.02</cell><cell>.00</cell><cell>5.32</cell><cell>0.64</cell><cell>44.38</cell><cell>.12</cell></row><row><cell></cell><cell>Grenoble</cell><cell>1.33</cell><cell>0.39</cell><cell>4.54</cell><cell>.65</cell><cell>0.84</cell><cell>0.41</cell><cell>1.73</cell><cell>.64</cell></row><row><cell>Phl p 1</cell><cell>Lyon</cell><cell>0.74</cell><cell>0.26</cell><cell>2.12</cell><cell>.57</cell><cell>3.46</cell><cell>0.37</cell><cell>32.18</cell><cell>.28</cell></row><row><cell></cell><cell>Marseille</cell><cell>2.17</cell><cell>0.61</cell><cell>7.67</cell><cell>.23</cell><cell>-</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Montpellier</cell><cell>1.24</cell><cell>0.28</cell><cell>5.45</cell><cell>.78</cell><cell>0.76</cell><cell>0.07</cell><cell>7.86</cell><cell>.82</cell></row><row><cell></cell><cell>Grenoble</cell><cell>1.17</cell><cell>0.48</cell><cell>2.85</cell><cell>.72</cell><cell>1.17</cell><cell>0.31</cell><cell>4.33</cell><cell>.82</cell></row><row><cell>Der p 1</cell><cell>Lyon</cell><cell>0.64</cell><cell>0.19</cell><cell>2.12</cell><cell>.46</cell><cell>11.25</cell><cell>1.37</cell><cell>92.65</cell><cell>.02</cell></row><row><cell></cell><cell>Marseille</cell><cell>0.16</cell><cell>0.02</cell><cell>1.50</cell><cell>.11</cell><cell>-</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Montpellier</cell><cell>0.45</cell><cell>0.05</cell><cell>4.29</cell><cell>.48</cell><cell>0.57</cell><cell>0.14</cell><cell>2.34</cell><cell>.44</cell></row><row><cell></cell><cell>Grenoble</cell><cell>1.61</cell><cell>0.64</cell><cell>4.10</cell><cell>.31</cell><cell>3.39</cell><cell>1.00</cell><cell>11.47</cell><cell>.05</cell></row><row><cell>Der p 2</cell><cell>Lyon</cell><cell>0.53</cell><cell>0.16</cell><cell>1.71</cell><cell>.29</cell><cell>2.31</cell><cell>0.93</cell><cell>5.78</cell><cell>.07</cell></row><row><cell></cell><cell>Marseille</cell><cell>0.49</cell><cell>0.11</cell><cell>2.28</cell><cell>.36</cell><cell>1.57</cell><cell>0.53</cell><cell>4.63</cell><cell>.41</cell></row><row><cell></cell><cell>Montpellier</cell><cell>0.68</cell><cell>0.12</cell><cell>4.01</cell><cell>.67</cell><cell>5.23</cell><cell>0.62</cell><cell>44.38</cell><cell>.13</cell></row><row><cell></cell><cell>Grenoble</cell><cell>2.07</cell><cell>0.83</cell><cell>5.17</cell><cell>.12</cell><cell>1.98</cell><cell>0.89</cell><cell>4.40</cell><cell>.10</cell></row></table><note><p><s>*OR (reference: Paris) adjusted for age, sex, asthma status, and rhinitis status.</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">J ALLERGY CLIN IMMUNOLFEBRUARY 2017</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">J ALLERGY CLIN IMMUNOL VOLUME 139, NUMBER 2</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">J ALLERGY CLIN IMMUNOL FEBRUARY 2017 654.e4 SIROUX ET AL</note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0" />			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">The future of antigen-specific immunotherapy of allergy</title>
		<author>
			<persName><forename type="first">R</forename><surname>Valenta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="446" to="453" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Development of immunoglobulin G subclass antibodies to ovalbumin, birch and cat during the first eight years of life in atopic and non-atopic children</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Jenmalm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Bjorksten</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Allergy Immunol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="112" to="121" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Immunoglobulin G in IgE-mediated allergy and allergen-specific immunotherapy</title>
		<author>
			<persName><forename type="first">S</forename><surname>Hofmaier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Comberiati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Matricardi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Ann Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="6" to="11" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Allergen immunotherapy and tolerance</title>
		<author>
			<persName><forename type="first">T</forename><surname>Matsuoka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Shamji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Durham</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergol Int</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="403" to="413" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens</title>
		<author>
			<persName><forename type="first">M</forename><surname>Akdis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Akdis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="621" to="631" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Immunological mechanisms of allergen-specific immunotherapy</title>
		<author>
			<persName><forename type="first">M</forename><surname>Larche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Akdis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Valenta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="761" to="771" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Regulatory functions of B cells in allergic diseases</title>
		<author>
			<persName><forename type="first">F</forename><surname>Braza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chesne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Castagnet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Magnan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Brouard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="1454" to="1463" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Microarrayed dog, cat, and horse allergens show weak correlation between allergenspecific IgE and IgG responses</title>
		<author>
			<persName><forename type="first">M</forename><surname>Curin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Swoboda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Wollmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lupinek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Spitzauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Van Hage</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="918" to="921" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>e6</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Longitudinal study on the relationship between cat allergen and endotoxin exposure, sensitization, cat-specific IgG and development of asthma in childhood-report of the German Multicentre Allergy Study (MAS 90)</title>
		<author>
			<persName><forename type="first">S</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Illi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Platts-Mills</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Riposo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Nickel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gruber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="766" to="773" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Changes in cat specific IgE and IgG antibodies with decreased cat exposure</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Erwin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Woodfolk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>James</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Satinover</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Platts-Mills</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Allergy Asthma Immunol</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="545" to="550" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>e1</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Default&apos;&apos; versus &apos;&apos;pre-atopic&apos;&apos; IgG responses to foodborne and airborne pathogenesis-related group 10 protein molecules in birch-sensitized and nonatopic children</title>
		<author>
			<persName><forename type="first">S</forename><surname>Hofmaier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Hatzler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rohrbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Panetta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hakimeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Bauer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="1367" to="1374" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>e8</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment</title>
		<author>
			<persName><forename type="first">R</forename><surname>Hiller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Laffer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Harwanegg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Huber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Twardosz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FA-SEB J</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="414" to="416" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">)LEN consensus document on molecular-based allergy diagnostics</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Canonica</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Ansotegui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pawankar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Schmid-Grendelmeier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Van Hage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Baena-Cagnani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">World Allergy Organ J</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">17</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">The ImmunoCAP ISAC molecular allergology approach in adult multi-sensitized Italian patients with respiratory symptoms</title>
		<author>
			<persName><forename type="first">G</forename><surname>Melioli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bonifazi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bonini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Maggi</forename><forename type="middle">E</forename><surname>Mussap</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Passalacqua</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Biochem</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="1005" to="1011" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">MeD-ALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Anto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Auffray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Akdis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cambon-Thomsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Keil</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="596" to="604" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip</title>
		<author>
			<persName><forename type="first">C</forename><surname>Lupinek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Wollmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Baar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Banerjee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Breiteneder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Broecker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Methods</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="106" to="119" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">The use of the MeDALL-chip to assess IgE sensitization: a new diagnostic tool for allergic disease?</title>
		<author>
			<persName><forename type="first">I</forename><surname>Skrindo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lupinek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Valenta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Hovland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pahr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Baar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Allergy Immunol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="239" to="246" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Early childhood IgE reactivity to pathogenesis-related class 10 proteins predicts allergic rhinitis in adolescence</title>
		<author>
			<persName><forename type="first">M</forename><surname>Westman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lupinek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Andersson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pahr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Baar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="e1" to="11" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">EGEA (Epidemiological study on the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy)-descriptive characteristics</title>
		<author>
			<persName><forename type="first">F</forename><surname>Kauffmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Dizier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Annesi-Maesano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Charpin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Demenais</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Allergy</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="17" to="21" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Ten-year follow-up of cluster-based asthma phenotypes in adults: a pooled analysis of three cohorts</title>
		<author>
			<persName><forename type="first">A</forename><surname>Boudier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Curjuric</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Basagana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hazgui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Anto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">188</biblScope>
			<biblScope unit="page" from="550" to="560" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Phenotypic determinants of uncontrolled asthma</title>
		<author>
			<persName><forename type="first">V</forename><surname>Siroux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Boudier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Bresson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Cracowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ferran</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="page" from="681" to="687" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">EGEA (Epidemiological study on the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy)-design issues. EGEA Co-operative Group</title>
		<author>
			<persName><forename type="first">F</forename><surname>Kauffmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Dizier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Allergy</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="19" to="22" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Epidemiological study of the genetics and environment of asthma, bronchial hyperresponsiveness, and atopy: phenotype issues</title>
		<author>
			<persName><forename type="first">F</forename><surname>Kauffmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Dizier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Pin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Paty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Gormand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Vervloet</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">156</biblScope>
			<biblScope unit="page" from="S123" to="129" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Natural clinical tolerance to peanut in African patients is caused by poor allergenic activity of peanut IgE</title>
		<author>
			<persName><forename type="first">E</forename><surname>Wollmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hamsten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sibanda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ochome</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Focke-Tejkl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Asarnoj</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="638" to="652" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">The pollen-associated allergic risk in France</title>
		<author>
			<persName><forename type="first">M</forename><surname>Thibaudon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allerg Immunol</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="170" to="172" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note>in French</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">D evelopement temporel et g eographique des allerg enes polliniques principaux en France</title>
		<author>
			<persName><forename type="first">M</forename><surname>Thibaudon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Caillier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allerg Immunol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="154" to="157" />
			<date type="published" when="1987">1987-2001. 2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever</title>
		<author>
			<persName><forename type="first">L</forename><surname>Hatzler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Panetta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Bergmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Illi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">130</biblScope>
			<biblScope unit="page" from="894" to="901" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>e5</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">A comprehensive analysis of middle-European molecular sensitization profiles to pollen allergens</title>
		<author>
			<persName><forename type="first">P</forename><surname>Panzner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vachova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Vitovcova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Brodska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Vlas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int Arch Allergy Immunol</title>
		<imprint>
			<biblScope unit="volume">164</biblScope>
			<biblScope unit="page" from="74" to="82" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">A molecular diagnostic algorithm to guide pollen immunotherapy in southern Europe: towards component-resolved management of allergic diseases</title>
		<author>
			<persName><forename type="first">N</forename><surname>Douladiris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Savvatianos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Roumpedaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Skevaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Mitsias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">G</forename><surname>Papadopoulos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int Arch Allergy Immunol</title>
		<imprint>
			<biblScope unit="volume">162</biblScope>
			<biblScope unit="page" from="163" to="172" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Effect of measurement error on epidemiological studies of environmental and occupational exposures</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">G</forename><surname>Armstrong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Occup Environ Med</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="651" to="656" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Prevalence of allergic sensitization in the United States: results from the National Health and Nutrition Examination Survey (NHANES) 2005-2006</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Salo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Arbes</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jaramillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Calatroni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Weir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Sever</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="page" from="350" to="359" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Allergy in the Mediterranean area, III: cross reactivity among Oleaceae pollens</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Guerin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hewitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">B</forename><surname>Michel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Allergy</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="439" to="448" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">The major allergen of olive pollen Ole e 1 is a diagnostic marker for sensitization to Oleaceae</title>
		<author>
			<persName><forename type="first">O</forename><surname>Palomares</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Swoboda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Villalba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Balic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Spitzauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rodriguez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int Arch Allergy Immunol</title>
		<imprint>
			<biblScope unit="volume">141</biblScope>
			<biblScope unit="page" from="110" to="118" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Sal k 5, a member of the widespread Ole e 1-like protein family, is a new allergen of Russian thistle (Salsola kali) pollen</title>
		<author>
			<persName><forename type="first">L</forename><surname>Castro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Barderas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Colas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Garcia-Selles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Barber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int Arch Allergy Immunol</title>
		<imprint>
			<biblScope unit="volume">163</biblScope>
			<biblScope unit="page" from="142" to="153" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Birch-pollen sensitization in an area without atmospheric birch pollens</title>
		<author>
			<persName><forename type="first">M</forename><surname>Yamagiwa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hattori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kanba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tasaki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Auris Nasus Larynx</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="261" to="266" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Componentresolved diagnosis (CRD) of type I allergy with recombinant grass and tree pollen allergens by skin testing</title>
		<author>
			<persName><forename type="first">S</forename><surname>Heiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Mahler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Steiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Spitzauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schweiger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kraft</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Invest Dermatol</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="830" to="837" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation</title>
		<author>
			<persName><forename type="first">S</forename><surname>Vrtala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ball</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Spitzauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Pandjaitan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Suphioglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Knox</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">160</biblScope>
			<biblScope unit="page" from="6137" to="6144" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Profilins constitute a novel family of functional plant pan-allergens</title>
		<author>
			<persName><forename type="first">R</forename><surname>Valenta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Duchene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ebner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Valent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sillaber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Deviller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">175</biblScope>
			<biblScope unit="page" from="377" to="385" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Identification of allergens in fruits and vegetables: IgE cross-reactivities with the important birch pollen allergens Bet v 1 and Bet v 2 (birch profilin)</title>
		<author>
			<persName><forename type="first">C</forename><surname>Ebner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hirschwehr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Breiteneder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Valenta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ebner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="962" to="969" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Der p 11 is a major allergen for house dust mite-allergic patients suffering from atopic dermatitis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Banerjee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Resch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Swoboda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Focke-Tejkl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Blatt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Invest Dermatol</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="102" to="109" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
